In summary, our findings demonstrate a dose-dependent increase in the incidence of pre-hypertension and hypertension with rising AIP levels, revealing a statistically significant correlation between these parameters (P for trend <0.001) (Figure 3, Table 3). The gene discussed is AIP; the disease is Hypertension.